An elevated serum lactate level is associated with morbidity and mortality in patients with severe sepsis and septic shock. In patients with hepatic dysfunction, however, an elevated serum lactate level may be due to either impaired lactate clearance or excessive production. Thus, we evaluated whether the initial serum lactate level was also associated with mortality in septic shock patients with hepatic dysfunction. A retrospective observational study enrolled 307 patients with septic shock admitted to the intensive care unit (ICU) between May 2007 and July 2009. Hepatic dysfunction was defined as a serum total bilirubin >34.2 µmol/l (2 mg/dl). Selected patients were divided into high (≥4 mmol/l) and low (<4 mmol/l) lactate groups, according to the initial serum lactate level. Of 307 patients with septic shock, 118 (38%) patients with hepatic dysfunction were eligible for this study. The median lactate levels were 5.9 (interquartile range 4.7 to 9.0) and 2.6 (interquartile range 1.7 to 3.2) mmol/l for the high and low lactate groups respectively (P <0.001). The initial serum lactate level was strongly associated with in hospital mortality in a univariate analysis (P <0.001). After adjusting for potential confounding factors, the initial serum lactate level remained significantly associated with in-hospital mortality (odds ratio 1.281, 95% confidence interval 1.097 to 1.496, P=0.002). In conclusion, the serum lactate level could be useful in predicting the outcome of patients with septic shock regardless of hepatic dysfunction.
Sepsis affects the cardiovascular system through multiple mechanisms and these derangements often result in tissue hypoperfusion 1, 2 , an important factor in the development of multiple organ failure 3, 4 , and inadequate tissue oxygenation increases serum lactate via anaerobic glycolysis 5 . Thus, lactate is a useful, clinically obtainable surrogate marker of tissue hypoxia and disease severity in patients with septic shock [6] [7] [8] . However, an elevated serum lactate level may be due to impaired lactate clearance and/or excess production in sepsis 9, 10 . Thus, septic patients with impaired lactate clearance may have a higher lactate compared with the patients without impaired lactate clearance but may, in fact, have a similar degree of tissue hypoperfusion.
Lactate is cleared primarily by the liver, but the kidneys and skeletal muscles are also involved 5 . In normal individuals, about half of the lactate produced is removed from the circulation by the liver 11 . Thus, in patients with hepatic dysfunction, impaired lactate clearance contributes to elevated serum lactate levels 9, 10 .
Many studies have reported that serum lactate is a potentially useful prognostic marker of global tissue hypoxia in patients with circulatory shock, including septic shock [6] [7] [8] . However, a single measurement of the lactate concentration is difficult to interpret, especially in patients with hepatic dysfunction, because it represents a balance between lactate production and elimination. Thus, it is unclear whether an elevated serum lactate level is also associated with outcome in patients with hepatic dysfunction. Consequently, this study evaluated whether the initial serum lactate level was also associated with mortality in septic shock patients with hepatic dysfunction.
MATERIALS AND METHODS
This retrospective observational study was conducted at Samsung Medical Centre (a universityaffiliated, tertiary referral hospital in Seoul, South Korea) between May 2007 and July 2009. Over the study period, all patients with septic shock, defined as sepsis with hypotension (systolic blood pressure <90 mmHg) despite adequate fluid resuscitation or the use of vasoactive agents 12 , admitted to the intensive care unit (ICU) through the emergency department or a general ward were eligible for this study. Patients who were younger than 18 years or did not have lactate or total bilirubin levels measured were excluded. Of 307 patients with septic shock who were admitted to the ICU during the study period, 118 (38%) patients with hepatic dysfunction, defined as a serum total bilirubin >34.2 µmol/l (2 mg/dl) 13 , were ultimately included in the analysis.
Approval was obtained from the institutional review board of Samsung Medical Centre to review and publish information from the patients' records. Informed consent was waived because of the retrospective nature of the study.
The following clinical data were extracted from medical records: age, gender, comorbidities (hypertension, diabetes, cirrhosis, chronic renal failure), sites of infection and laboratory data. The Simplified Acute Physiology Score (SAPS) 3 and Sequential Organ Failure Assessment (SOFA) score at the time of ICU admission were calculated to assess the severity of illness. The initial serum lactate level (mmol/l) was measured with a serum-based enzymatic colorimetry method, using a Modular DDP analyzer (Roche Hitachi, Tokyo, Japan). The patients were divided into two groups according to the initial serum lactate level. The high and low lactate groups included patients separated by an initial serum lactate level of 4 mmol/l.
Statistical analysis
Data are presented as medians and interquartile ranges (IQR, 25th and 75th percentiles) for continuous variables and as numbers (percentages) for categorical variables. Data were compared using the Mann-Whitney U test for continuous variables and the chi-squared or Fisher's exact test for categorical variables. Multiple logistic regression analysis was used to adjust for potential confounders in the association between the initial serum lactate level and hospital mortality 14 . We adjusted for age, gender, severity of illness, assessed by the SOFA score and SAPS 3, comorbidities related to impaired lactate clearance, and finally for all variables related to the outcome in the univariate analysis at a P value of 0.05. A forward selection model, using the entry criterion P ≤0.05, was used. The adjusted odds ratio (OR) with the 95% confidence interval (CI) were calculated in the final model. The Hosmer-Lemeshow test was used to check the goodness-of-fit of the logistic regression. All tests were two-sided, and a P value <0.05 was deemed significant. Data were analysed using PASW Statistics 17 (SPSS, Chicago, IL, USA).
RESULTS
The baseline characteristics of the 118 septic shock patients with hepatic dysfunction are summarised in Table 1 . There were 74 males and 44 females, with a median age of 62 (IQR 53 to 70) years. Twenty (17%) patients had liver cirrhosis. In these patients, the most frequent sites of infection were the abdomen (n=51, 43%), respiratory tract (n=26, 22%), soft tissues (n=13, 11%) and genitourinary tract (n=9, 8%). The median SOFA score and SAPS 3 at the time of admission to the ICU was 12 (9 to 14) and 80 (69 to 92), respectively. The median initial lactate level was 3.4 (2.3 to 5.5) mmol/l. The ICU mortality and in-hospital mortality rates were 36 and 48%, respectively, and the median lengths of the ICU and hospital stays were four (2 to 9) and 19 (12 to 2) days, respectively.
The patients were first divided into two groups, according to their initial serum lactate level. The baseline characteristics of each group are presented in Table 2 . The median lactate level was 2.6 (1.7 to 3.2) and 5.9 (4.7 to 9.0) mmol/l in the low and high lactate groups, respectively (P <0.001). Cirrhosis was more common in the high lactate group (11% vs 26%; P=0.043). The patients in the high lactate group had more severe illnesses and had higher ICU mortality rates than the patients in the low lactate group (27% vs 51%; P=0.011), However, there was no significant difference in in-hospital mortality between the groups (42% vs 57%; P=0.076).
In total, 57 patients died during their hospital stays. Univariate comparisons of baseline characteristics between survivors and non-survivors are reported in Table 3 . There was no significant difference in age, gender, comorbidities or sites of infection except for abdominal infection, which was less common in non-survivors. However, the initial lactate level was significantly associated with hospital mortality, which was greater in non-survivors than survivors (P=0.011). Additionally, the need for mechanical ventilation, SOFA score, and SAPS 3 at the time of admission to ICU were greater in non-survivors. The final multiple logistic regression model included the a priori variables age, gender, SOFA score, SAPS 3, cirrhosis, chronic renal failure, abdominal infection, prothrombin time, albumin and the need for mechanical ventilation, which were significantly associated with the outcome in the univariate analysis (Table 3 ). In the multiple logistic regression analysis, after adjusting for potential confounding factors, the initial serum lactate level was still significantly associated with hospital mortality (odds ratio 1.281, 95% confidence interval 1.097 to 1.496, P <0.002; Hosmer-Lemeshow chi-squared test 6.345; P=0.609; Table 4 ). Additionally, the SAP 3 (odds ratio 1.034, 95% confidence interval 1.009 to 1.060; P=0.007) and need for mechanical ventilation (odds ratio 6.651, 95% confidence interval 2.557 to 17.301; P <0.001) were independently associated with hospital mortality (Table 4) .
DISCUSSION
This study evaluated whether the initial lactate level, measured at presentation with septic shock, is a potential prognostic marker of mortality in patients with hepatic dysfunction, in whom the elevated serum lactate level might be due to impaired lactate clearance and/or excess production. Our results demonstrated that an elevated serum lactate level was independently associated with hospital mortality after adjusting for potential confounding factors. This result is consistent with a recent report that the initial serum lactate is associated with mortality, independent of organ dysfunction, in patients with severe sepsis or septic shock 13 . A systemic imbalance between oxygen delivery and demand causes an elevated serum lactate level 15 . Thus, increased lactate levels have been used to indicate the presence of tissue hypoxia, which can result in cell death and lead to organ failure. The blood lactate concentration is a parameter widely used in the ICU to assess tissue oxygenation and an elevated serum lactate level is strongly associated with morbidity and mortality in patients with septic shock [6] [7] [8] . In sepsis, however, an elevated serum lactate level may be due to impaired lactate clearance and/or excessive production 9,10 . Thus, it is unclear whether an elevated serum lactate level is simply a manifestation of tissue hypoperfusion, which increases serum lactate through anaerobic glycolysis due to inadequate tissue oxygenation 5 . In particular, because the liver is the major organ responsible for lactate elimination from the circulation, the serum lactate level in patients with hepatic dysfunction could be higher than in those without hepatic dysfunction 9, 10 . Thus, a single measurement of lactate concentration is difficult to interpret, especially in patients with hepatic dysfunction.
In patients with circulatory failure, De Jonghe et al reported that early hepatic dysfunction results in a significantly higher lactate level than in those without hepatic dysfunction 10 . Additionally, they suggested that, not only tissue hypoxia, but also early hepatic dysfunction contributed to blood lactate elevation in shock. These results raise doubts about the reliability of hyperlactataemia as an indicator of the intensity of tissue hypoperfusion in septic shock patients with organ dysfunction, especially liver dysfunction.
Mikkelsen et al examined the association between initial serum lactate levels and mortality in sepsis patients with organ dysfunction and shock 13 . They found that the initial serum lactate level was associated with mortality in patients with clinically apparent organ failure, such as central nerve system failure, coagulation failure and hepatic failure, regardless of shock. Additionally, after adjusting for potential confounding factors, including hepatic failure, the association remained significant in patients with shock. However, hepatic dysfunction was measured in approximately 58% of their patients and few had hepatic failure (12%), which could limit the generalisability of their findings to other patients with hepatic dysfunction. Thus, our study included only septic shock patients with hepatic dysfunction, defined as a serum total bilirubin >34.2 µmol/l (2 mg/dl) 13 . Although hyperlactataemia in septic shock with hepatic dysfunction might occur due to impaired lactate clearance, as well as excess production, we found that the initial serum lactate level was independently associated with mortality. Thus, a single measurement of serum lactate may potentially be a useful biomarker to risk-stratify patients with septic shock regardless of hepatic dysfunction.
Clinical assessment of early hepatic dysfunction is difficult because there are no standardised, well accepted criteria to measure hepatic dysfunction. We used isolated serum bilirubin to measure hepatic dysfunction because various severity scores such as SOFA score include a marker of liver dysfunction using serum bilirubin in the scoring system. In addition, organ failure could be defined as SOFA score of 2 or more per system 16 . Therefore, a threshold value of 34.2 µmol/l (2 mg/dl) which is SOFA score of 2 in the hepatic system was chosen to define patients with hepatic dysfunction in this study, although this threshold was used as alternative definition in another study defining hepatic dysfunction 13 .
There are several limitations to this study. First, given its retrospective nature, there is always the possibility that selection bias influenced the significance of our findings. Data on how many patients with a high risk of death who had been refused ICU admission or further management during the study period could not be extracted from the medical records. Thus, we could not evaluate the potential influence of the limitations of care decisions on outcome in this group. Second, we could not evaluate the effects of renal failure on the association between the elevated serum lactate level and mortality. Although the liver has long been recognised as a key organ in lactate homeostasis, the kidney is also involved in lactate elimination from the circulation 17 . In patients with renal failure, the serum lactate level might be elevated due to impaired lactate clearance. However, the number of patients with chronic renal failure was too small to confound the association between the elevated serum lactate level and mortality in this study. Third, not only the serum lactate level, but also lactate clearance could be a predictor of mortality in septic shock patients 8, 18 . Serial measurements of the lactate clearance over time may be better predictors of morbidity and mortality in sepsis or septic shock 8 . Additionally, lactate clearance in the first six hours of hospitalisation is associated with improved morbidity and mortality in severe sepsis and septic shock 18 . In our study however, lactate clearance over time could not be determined because of incomplete medical records.
In conclusion, we found that the initial serum lactate level was independently associated with in-hospital mortality in septic shock patients with hepatic dysfunction. Thus, the measurement of serum lactate level could be useful in predicting the outcome of patients with septic shock, regardless of hepatic dysfunction.
